(PR-inside.com) http://www.molecularinsight.com - The Board of Directors of Molecular Insight Pharmaceuticals, Inc. (the 'Company') (NASDAQ: MIPI) announced today that John Babich, President and Chief Scientific Officer of the Company, will replace David S. Barlow as the Company's interim CEO and Chairman of the Board, effective immediately. Mr. Barlow will continue to serve out his term as a member of the Company's Board of Directors. The Company had begun a search to identify a permanent CEO. The Company's Board said: 'The Board determined that new leadership at the Chair and CEO level was necessary for the Company to execute on its ..
More...
More...